ESC 2018

Coronary CTA Superior to Standard Care in Stable Chest Pain

Coronary CTA Superior to Standard Care in Stable Chest Pain

By

Coronary computed tomographic angiography was associated with a lower 5-year mortality rate in patients with stable chest pain.

SAVR vs TAVR: Adverse Outcomes Risk in Aortic Stenosis

SAVR vs TAVR: Adverse Outcomes Risk in Aortic Stenosis

By

Surgical and transcatheter aortic valve replacement had a similar risk for adverse outcomes in patients with severe aortic stenosis, regardless of whether or not the patients had prior cardiac surgery.

Outcomes With Rivaroxaban in Chronic Heart Failure With Underlying CAD

Outcomes With Rivaroxaban in Chronic Heart Failure With Underlying CAD

By

Rivaroxaban was not superior to placebo for reducing the rate of death, MI, or stroke in patients with chronic heart failure.

Tafamidis Reduces Mortality, Hospitalizations in Transthyretin Amyloid Cardiomyopathy

Tafamidis Reduces Mortality, Hospitalizations in Transthyretin Amyloid Cardiomyopathy

By

Tafamidis was associated with reduced all-cause mortality and cardiovascular-related complications in patients with transthyretin amyloid cardiomyopathy.

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

Statins, CCBs Confer Long-Term Mortality Benefit in Hypertension

By

Mortality benefits from atorvastatin- and amlodipine-based antihypertensive treatments extend beyond 10 years of treatment.

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

By

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

By

Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.

Coronary CTA Associated With Lower Death Rate in CHD, Nonfatal MI

Coronary CTA Associated With Lower Death Rate in CHD, Nonfatal MI

There was a lower death rate from coronary heart disease and non-fatal MI at 5 years in patients with stable chest pain.

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

By

The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.

Lorcaserin Facilitates Weight Loss Without Increasing Risk of Major CV Events

Lorcaserin Facilitates Weight Loss Without Increasing Risk of Major CV Events

By

In the CAMELLIA-TIMI 61 study, 12,000 overweight or obese patients with atherosclerotic cardiovascular disease or multiple cardiovascular risk factors were randomized to receive either lorcaserin 10mg twice daily or placebo.

Does Aspirin Cut the Risk of Initial Vascular Events in Patients at Moderate CVD Risk?

Does Aspirin Cut the Risk of Initial Vascular Events in Patients at Moderate CVD Risk?

For this double-blind, placebo-controlled study, researchers selected male patients ≥55 years and female patients ≥60 years with average cardiovascular risk and assigned them to enteric-coated aspirin 100mg (N=6270) or placebo (N=6276) once daily; the median follow-up time was 60 months.

Sign Up for Free e-Newsletters